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Abstract Adaptation of Borrelia burgdorferi in the vector
and vertebrate host is mediated by mechanisms that
regulate diﬀerential expression of outer surface lipo-
proteins (Osps). In this study, real time PCR was applied
to quantify tissue-speciﬁc expression of four linear
plasmid (lp54)-encoded (ospA, zs7.a36, zs7.a66 zs7.a68)
and one circular plasmid (cp26)-encoded (ospC) gene
from B. burgdorferi sensu stricto, in a natural setting of
tick-infected immunodeﬁcient (C.B-17 SCID) and
immunocompetent (BALB/c and AKR/OlaHsd) mice
for up to 120 days post-infection (p.i.). Early during
infection (day 30 p.i.) high numbers of spirochetes were
found in the heart and joint, but not the ear and spleen
tissues of disease-susceptible SCID mice. In disease-
susceptible AKR mice spirochetes colonized the ear and
joint tissues, but were undetectable in tissues of disease-
resistant BALB/c mice. Later in infection (day 120 p.i.),
spirochetes had expanded (1,000-fold) in all SCID
tissues tested but were undetectable in AKR and BALB/
c mice. Of the ﬁve genes analyzed, only zs7.a36 tran-
scripts were detected in various tissues of all infected
mouse strains, though at diﬀering levels, whereas ospC
transcripts were only found in tissue specimens of SCID
mice. Furthermore, gene expression of ospC and zs7.a36
appears to be diﬀerentially regulated in distinct organs
of individual mice. In contrast, transcripts for ospA,
zs7.a66, and zs7.a68 were not detected in any of the
mouse strains, independent of their immune status and/
or the severity of their infection/inﬂammatory responses.
Late during infection (day 120 p.i.), transcription of
zs7.a36 and ospC was down-regulated in the tissues of
SCID mice despite expansion of spirochetes. This type
of quantitative analysis may be helpful to further dis-
close principles of pathogenesis of Lyme borreliosis and
to design strategies for its therapeutic treatment.
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Introduction
Lyme disease in humans is caused by three genospecies
of the Borrelia burgdorferi sensu lato (B.b.s.l.) complex;
B.b. sensu stricto (s.s.), B. afzelii, and B. garinii. Co-
evolution of this tick-borne spirochete and mice, its
main natural reservoir host [3], have led to a steady state
between pathogen and mammals that is characterized, in
most cases, by persistence of B. burgdorferi and lack of
disease symptoms in the carrier [57]. There is increasing
evidence that the pathogen has evolved various strate-
gies to evade innate and adaptive immunity, including
binding of host-derived factors, such as plasminogen [21]
and complement inhibitors [31], diﬀerential up- and
down-regulation of outer surface proteins (Osp) [2, 15,
38,57] and antigenic variation [65]. In fact, recent data
suggest that speciﬁc antibodies to OspC may select for
surface-antigen non-expressors thereby contributing to
spirochetal persistence in mice [36]. However, many osp
genes, which are expressed in spirochetes seeding unfed
ticks, e.g. ospA and zs7.a68, lp6.6 seem to be inactive in
mammals, independent of the immune status of the host
[16, 34, 41, 56, 61,67]. Other spirochetal genes, e.g. ospC,
bbk32, bbk50, and zs7.a36, are likely to be expressed by
spirochetes during the entire enzootic cycle, including
the arthropod vector and the mammalian host [19, 56,
61,67]. Yet another group of B. burgdorferi genes, e.g.
eppA, pG, p21, bbK2.10, and p35, seem to be selectively
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expressed in the mammalian environment, at least tem-
porarily [1, 2, 10, 14, 15, 59,60].
To date there is little information available on whe-
ther the various in vivo expressed spirochetal surface
antigens are suitable candidates for immunotherapy.
The feasibility of targeting and eliminating spirochetes
during chronic infection in mice is indicated by our re-
cent ﬁndings that passive transfer of OspC-speciﬁc Ab
leads to resolution of chronic B. burgdorferi s.s. infec-
tion, elicited by either experimental or tick challenge in
immunodeﬁcient and -competent mice [66,67]. However,
such an approach may be invalidated by the selection of
variants that do not express OspC under diﬀerent con-
ditions [36]. Moreover, the recent ﬁnding that upon
feeding, homogeneous populations of B. burgdorferi
within the tick gut give rise to transmittable progenies
with extensive antigenic heterogeneity adds a further
dimension to the problem of immune surveillance [44]. It
is thus clear that only detailed knowledge of the regu-
lation of B. burgdorferi gene expression in situ will help
to elucidate those structures, which are integral to spi-
rochetal persistence and thus of relevance for the
development of therapeutic regimens.
To date, all studies but one [64], in which B. burg-
dorferi s.s. was quantiﬁed in mouse tissue samples, were
pursued with needle-inoculated recipients [42, 45,62],
and only in one case was B. burgdorferi gene expression
examined in skin specimens of naturally (tick) chal-
lenged C3H mice for up to 2 weeks [28]. In light of the
notion that needle exposure by no means reﬂects the
situation of tick infection [23, 25,54] and the highly
improved real-time PCR technique to quantify B.
burgdorferi in situ [24, 27, 43, 46, 48, 62, 63,64], we have
now performed a detailed quantitative analysis of the
spirochete burden and population dynamics in diﬀerent
tissues of mice following natural (tick) infection by B.
burgdorferi s.s. (ZS7) for a period of 4 months post-
infection (p.i.). For this purpose we have selected one
cp26-encoded gene, ospC [40], and four previously de-
scribed lp54-encoded genes, i.e. ospA, zs7.a36, zs7.a66,
and zs7.a68 [20,61]—the respective antigens of which are
suggested to be either putative vaccine candidates [61,66]
and/or relevant for complement resistence [32]—and
three strains of mice with distinct immune status and
susceptibility to B. burgdorferi s.s.-induced disease/
infection [50,53].
Materials and methods
Mice, spirochetes, ticks and infection
Adult female mice of strains C.B-17 SCID (H-2d,
SCID), AKR/OlaHsd (H-2k, AKR), and BALB/c (H-
2d) were bred under speciﬁc pathogen-free conditions
at the Max-Planck-Institut fu¨r Immunbiologie, Frei-
burg, Germany. Animals between 6 and 8 weeks of
age were used throughout the experiments. For tick-
mediated infection of mice, 10–12 Ixodes ricinus
nymphs, previously fed on ZS7 B. burgdorferi (s.s.)
infected mice (L. Gern, Neuchaˆtel, Switzerland) [22],
were let feed on each mouse until saturation (4–6
days). The ﬁrst day of feeding was considered day one
of the infection. Mice were monitored for clinical
symptoms (arthritis), blood was taken on days 30 or
60 for serological analysis and organs were removed
on days 30 or 120 from the respective infected mice,
including from uninfected controls, for DNA/RNA
isolation, as described.
Serology
ELISA was used to quantify B. burgdorferi-speciﬁc
antibodies in infected mice. Plates were coated with B.
burgdorferi ZS7 sonicate [50] at 10 lg/ml. A standard
curve was generated with mAb LA2 (IgG2b) [33] at
1 mg/ml and the second Ab goat anti-mouse Ig-AP
(SBA-Birmingham, Ala.) at 1:2,000. Mouse sera were
tested at dilutions of 1:50 and incubated 2 h at room
temperature.
DNA isolation from murine tissue
For genomic DNA isolation, tissue pieces (30–50 mg,
equivalent to 1/2 heart, 1/3 spleen, whole ear or joint)
were added to 1,000 ll 0.1% (1 mg/ml) collagenase A
(Roche) in PBS, and incubated 4–6 h at 37C, with
shaking. An equal volume of 0.2 mg/ml proteinase K
(Gibco BRL) was added in the following buﬀer:
200 mM NaCl, 20 mM TrisHCl pH8, 50 mM EDTA
pH8, plus 1% SDS. Samples were incubated overnight
at 55C, with occasional shaking. DNA was recovered
with 1.7 ll glycogen (Boehringer Mannheim, 20 lg/ll
stock solution) and an equal amount of isopropanol
and let precipitate at )80C. All samples were washed
twice with 80% EtOH. Pellets were resuspended in
180–360 ll molecular biology-grade water (Eppen-
dorf). The DNA concentration of each sample was
determined by photometric analysis. This protocol
generated higher yields of B. burgdorferi-speciﬁc DNA
than compared to phenol/chloroform extractions (data
not shown).
RNA isolation from murine tissue
Thirty to 50 mg of murine tissues were added to 1.5 ml
cold RNAzol (WAK-Chemie) and RNA was isolated
according to the manufacturer’s recommendations.
RNA was treated with DNAse I (Roche) for 30 min at
37C and cleaned according to the Phase Lock Gel
Heavy (Eppendorf) tube protocol. Concentrations were
measured photometrically.
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Real-time PCR
Real-time PCR using a LightCycler was carried out as
described by Roche Molecular Biochemicals with 18 ll
SYBR Green I Master Mix and 2 ll, at various DNA
concentrations, of sample. Average DNA yields from
the tissues of infected mice were: heart, 5.5·105 ng;
spleen, 1.8·106 ng; ear, 2.3·105 ng; joint, 4.5·105 ng.
The reaction conditions with primers for zs7.a66 and
zs7.a68 were as follows: initial denaturation at 95C for
10 min then 45 cycles at 95C for 15 s, 55C 5 s, 72C
10 s; melting curve at 95C 0 s, 65C 15 s, 95C 0 s at
0.1C/s; cooling at 40C 30 s. The annealing conditions
were altered to 56C for 8 s for zs7.a36 and hypoxan-
thine-guanine phosphoribosyltransferase (hprt), and to
50C for 8 s for ospC. The elongation time for the latter
primers was increased to 15 s. For OspA, the annealing
conditions were 55C for 8 s with a 25 s elongation time;
for ﬂagellin, the annealing step was also at 55C for 10 s,
and the elongation at 72C for 11 s. The following
plasmids were used as standards: pGEX-ZSA 36#1
containing zs7.a36 inserted into pGEX-2T (Promega)
(BamH1/EcoR1); pGEX-ZSA66(2)#20 with zs7.a66 in-
serted into pGEX 2T (BamH1/EcoR1); pGEX-
ZSA68(2)#7 with zs7.a68 inserted into pGEX-2T
(BamH1/EcoR1); pUEX-Spiro with ospC (without lea-
der) inserted into pGEX-2T (BamH1/EcoR1). pUEX-
Spiro#9 containing ﬂagellin inserted into
pUEX1(Amersham) (BamH1); pBOS-OspA#3 contain-
ing ospA inserted into pEF-BOS (BstX1). Puriﬁcation
was carried out using the Qiagen plasmid puriﬁcation kit
according to the high-copy plasmid protocol.
For control experiments to test real-time PCR sensi-
tivity (see Table 1): serial dilutions of cultured spiro-
chetes (from 105–100) were mixed with 30–50 mg of
mouse tissue (heart, spleen, ear, or joint) and processed
for DNA as described. Total DNA yields per whole
tissue (average whole tissue weights: heart, 75 mg;
spleen, 100 mg; ear, 30 mg; joint, 50mg) were as follows:
heart, 2.4·105 ng; spleen, 1.9·106 ng; ear, 1.4·105 ng;
joint, 3·104 ng. Tissue DNA was then diluted to a range
of 10–100 ng/ll for real-time PCR detection of B.
burgdorferi. Copy sensitivity limits correspond to num-
ber of theoretical B. burgdorferi present (after dilution)
per PCR reaction or ng tissue DNA.
Primers
Primers of the following sequences were obtained from
BIG Biotech GmbH: for zs7.a36, reverse 5¢ aaaga-
gatttctttaactcccg 3¢, forward 5¢ aagattgttgctcagtgggg 3¢ for
a 260 bp fragment. For zs7.a66, 5¢ gtgtgttagagttaagctgtgg
3¢, 5¢ ttcaagccgttacaaccgtacc 3¢ for a 348 bp fragment. For
zs7.a68, 5¢ catcaataagatcgtaaggacc 3¢, 5¢ tctggagaccttagca
cttctg 3¢ for a 180 bp fragment. For ospC, 5¢ ctgat-
gagtctgttaaagggcc 3¢, 5¢ gcttcagagcatttcttagctg 3¢ for a
300 bp fragment. For ospA, 5¢ tgtaagcaaaatgttagc 3¢, 5¢
aagttcaactgaaacttccc 3¢ for a 578 bp fragment. For
ﬂagellin, 5¢ gggtacagaattaatcgagc 3¢, 5¢ tgtatagaacctctg-
tctgc 3¢ for a 240 bp fragment. For hprt, HPRT 1 5¢
gctggtgaaaaggacctct 3¢, HPRT 2 5¢ cacaggactagaacacctgc
3¢ for a 250 bp fragment.
Quantitative real-time PCR assay
The real-time RT-PCR assay used the double-stranded
DNA-speciﬁc dye SYBR Green I. First-strand comple-
mentary DNA synthesis was performed on 3–30 lg of
DNAse I-treated total RNA with random hexamers and
AMV RT, using a ﬁrst strand RT kit (Roche). Ampli-
ﬁcation of the hprt gene on cDNA from mouse mRNA
was used as a control for total RNA extraction and for
the standardization of the results of target gene tran-
scriptional activity. The quantiﬁcation of each B. burg-
dorferi gene expression was performed on 20 ng of
cDNA preparations. At least two aliquots from each
mouse/tissue were tested in duplicate or triplicate in at
least two separate PCR reactions. Errors are given be-
tween separate cDNA dilutions tested on diﬀerent days.
The corresponding RNA samples not previously sub-
jected to reverse transcription were also ampliﬁed to
measure the amount of contaminating chromosomal
DNA. For all genes tested, no contamination by geno-
mic DNA was detectable after DNAse I treatment of
RNA, indicating speciﬁc detection of B. burgdorferi
cDNA (data not shown). For the determination of B.
burgdorferi gene expression in mouse tissues, the results
were standardized against hprt expression. Trace detec-
tion is indicated as <0.1 copies/100HPRT.
Quantiﬁcation of gene copy numbers
Quantitative analysis was performed using the LC soft-
ware (Roche Diagnostics). The generation of quantita-
tive data was based on the diﬀerent PCR kinetics of
samples with diﬀerent levels of target genes. We used a
relative quantiﬁcation in which the expression levels of
B. burgdorferi target genes were compared to the data
from a standard curve. Calculations were based on fol-
lowing data: 1 lg of 1.000 bp ds DNA =1.52 pmol. To
convert lg to pmol (for ds DNA) the following formula
was used: lg · 106 pg/1 lg · pmol/660 pg · 1/N =
pmol, where N is the number of nucleotides and
Table 1 Sensitivity of primer pairs for detection of Borrelia burg-
dorferi genes in plasmid DNA. The copy number is given as the
lowest reliable gene copy number per PCR (2 ll sample)
B. burgdorferi
gene
MgCl2
(mM)
Fragment
size (bp)
Plasmid standard Copy
number
Zs7.a36 3 260 pGEX-ZSA36#1 30
Zs7.a66 3.5 348 pGEX-ZSA66#20 300
Zs7.a68 3.5 180 pGEX-ZSA68#7 3
OspC 3 300 pGEX-ZSC#1 17
OspA 4 578 pbos OspA#3 30
Fla 3 240 pUEX Spiro#9 2
3
330 pmol/pg is the average MW of a nucleotide. The
amount of chromosome equivalent per microliter was
calculated considering the length of the B. burgdorferi
chromosome and plasmids, 1.5 Mb [20], and assuming
one copy per genome for the four genes analyzed. Copy
numbers quantiﬁed are averages from tests of at least
three concentrations of each DNA sample, tested in at
least two separate PCR reactions. No spirochetal DNA
could be ampliﬁed in tissues from uninfected control
mice.
B. burgdorferi culture and harvesting
Low passage ZS7 B. burgdorferi (third) were grown in
BSK-H (Sigma) medium and incubated at 32C at 5%
CO2. For all control experiments, Borrelia were grown
for 96 h to the exponential stage, visualized by dark ﬁeld
microscopy, counted with a Neubauer-improved
counting chamber, harvested by centrifugation at
10,500 g, 20C, for 20 min, and resuspended in cold
PBS.
Results
Sensitivity and speciﬁcity of real-time PCR for detection
of B. burgdorferi DNA
To deﬁne optimal conditions for the quantiﬁcation of B.
burgdorferi DNA by real time PCR, a set of primer pairs
speciﬁc for lp54-encoded ospA, zs7.a36, zs7.a66, zs7.a68,
and cp26-encoded ospC from strain ZS7 were tested on
plasmids harboring the respective genes by using various
experimental protocols adapted from previous studies
[7, 39, 47, 48,62]. Highest sensitivity was obtained for
zs7.a68 with a detection limit of about three copies/PCR
(Table 1, Fig. 1). Plotting the Ct values relative to the
number of individual plasmids resulted in a linear cor-
relation with a coeﬃcient (r) value of >0.98 for all genes
(Fig. 1B, shown only for pGEX-ZSA68). Applying
genomic DNA of B. burgdorferi ZS7 under similar
conditions, ‡10 copies of zs7.a68 could be detected with
high reproducibility (Table 2), which is in line with
previous reports [62, 63,64]. Due to the notion that
mutants of B. burgdorferi lacking the lp54 plasmid rarely
occur, if at all, in nature [30,49] and the assumption,
derived from the genomic sequence of B. burgdorferi B31
[20], that there is only one copy of zs7.a68 in the
spirochetal genome of strain ZS7 (B. burgdorferi s.s.),
zs7.a68 was used in all subsequent experiments in which
B. burgdorferi was quantiﬁed.
Next, the sensitivity of the real-time PCR was as-
sessed in specimens of unprocessed mouse tissue previ-
ously spiked with B. burgdorferi, to more readily reﬂect
the in vivo situation. When serial numbers of spirochetes
(100–105) were mixed with 30–50 mg of various mouse
tissues prior to DNA extraction zs7.a68 DNA was
detectable when PCR samples contained >100 (heart
and ear) and >600 (joint) spirochetes, respectively
(Table 1). This amounts to a detection limit of approx-
imately 1–7 spirochetes/ng tissue DNA. Notably, no B.
burgdorferi DNA was detectable in the context of spleen
tissue under these conditions. To compare the sensitivity
of our assay with a method described in a previous study
[62], spiking experiments were also carried out according
to the latter protocol (ie: 10–105 spirochetes were spiked
into 100 ll mouse heart digestion mixture prior to DNA
isolation). With this second spiking protocol, sensitivity
Fig. 1A, B Representative standard curve used in real-time PCR
for estimation of Borrelia burgdorferi-speciﬁc genes in plasmids and
mouse specimens. A representative titration of plasmid standard
pGEX-ZSA68 (3–3·105/PCR) using primer pairs for zs7.a68. B
standard curve of Ct versus log concentration of plasmid
Table 2 Sensitivity of real-time
PCR. Detection limits for B.
burgdorferi gene zs7.a68. Each
PCR reaction contained 2 ll of
sample at 10–100 ng/ll mouse
tissue DNA.N/ANot applicable
Test material Tissue Copy sensitivity
for quantiﬁcation/PCR
Copy sensitivity/ng
tissue DNA
pGEXZA68 DNA – ‡3 N/A
ZS7 B. burgdorferispirochetes – ‡10 N/A
B. burgdorferi (1–103/PCR) Heart ‡160 ‡1
Plus unprepared tissue Spleen Not detected Not detected
– Ear ‡148 ‡1
– Joint ‡680 ‡7
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was higher than with our ﬁrst protocol, as we could
detect single copies of B. burgdorferi using primer pairs
for both zs7.a68 (not shown) and the chromosome-en-
coded gene ﬂagellin (Fig. 2), also with a linear correla-
tion (Fig 2B). However, it is yet to be determined which
of the two protocols is more relevant to the in situ
conditions (see Discussion).
Quantiﬁcation of B. burgdorferi DNA
in tissue specimens of tick-infected mice
Disease-susceptible immunodeﬁcient (SCID) and
immunocompetent (AKR/OlaHsd) mice as well as
immunocompetent and disease-resistant BALB/c mice
[53] were challenged with infected ticks and the number
of spirochetes seeding various organs were determined
on days 30 and 120 p.i. (two mice/strain/time point).
Infection of individual mice was assessed either by the
development of clinical arthritis in SCID and AKR mice
and/or by seroconversion in AKR and BALB/c mice as
described (Table 3 and [53]). Accordingly, infected SCID
mice developed arthritis, which was already prominent
at day 21 p.i., and further increased in severity with time.
As reported before, the development of clinical arthritis
was less pronounced in AKR mice, but was clearly vis-
ible on day 68 p.i. [53]. AKR and BALB/c, but not
SCID mice generated speciﬁc antibodies to B. burgdor-
feri, the serum level of which increased with increasing
time of infection (Table 3).
Next, the spirochete burden was tested in heart, ear,
joint and spleen tissues of tick-infected SCID, AKR and
BALB/c mice at days 30 and 120 p.i.. On day 30 p.i.,
1–7 spirochetes/ng tissue DNA were detected in heart
and joint tissue samples of SCID mice (Table 4, Fig. 3).
No spirochetes were found in ear or spleen tissues of
SCID mice at this time point. By day 120 p.i., spirochete
numbers had increased by 3–4 orders of magnitude in
heart and joint tissue, and were now also present in
similar numbers in ear and spleen tissue of SCID mice
(Fig. 3, Table 4). In infected AKR mice, high numbers
of spirochetes (300–400 spirochetes/ng tissue DNA)
were found on day 30 p.i. in ear and joint tissues, but
were undetectable in heart and spleen tissues. On day
120 p.i., spirochetes were undetectable in all tested AKR
tissues. Finally, spirochetes were undetectable in the
tissues of infected BALB/c mice at both time points. A
summary of the kinetics of dissemination of B. burg-
dorferi is given in Fig. 3.
Fig. 2 A Representative titration of B.burgdorferi (4–4·104/PCR)
and an aliquot of digested heart tissue (according to Wang (62),
100 ng/PCR) together processed for DNA and analysed employing
ﬂagellin-speciﬁc primers. B standard curve of Ct versus log
concentration of B.burgdorferi
Table 3 Pathology and serology of B.burgdorferi (ZS7) infection.
The scores for severity of arthritis are given for the right and left
tibiotarsal joints according to the following scheme: ++ severe;
+ moderately severe; ± mild swelling; ± reddening; ) no clinical
signs. ND not detected
Strain Arthritis
(day 21)
B. burgdorferi
speciﬁc Ig
(lg/ml),
day 30
Arthritis
(day 68)
B. burgdorferi
speciﬁc Ig
(lg/ml),
day 60
C.B-17 SCID ++/+ ND
C.B-17 SCID ±/± ND
C.B-17 SCID ++/++ ND
C.B-17 SCID ++/++ ND
AKR/OlaHsd ) 7
AKR/OlaHsd ) 8.5
AKR/OlaHsd +/± 7.1
AKR/OlaHsd ±/± 11.6
BALB/c ) 7.2
BALB/c ) 9
BALB/c ) 20.4
BALB/c ) 27.9
Table 4 Summary of real-time PCR detection of ZS7 B. burgdor-
feri DNA in murine tissues. Copy numbers of zs7.a68 are given as
an average of two mice per group with standard deviations for all
samples tested. ND Not detected by real-time PCR. Spirochetal
DNA was undetectable in BALB/c mice at days 30 and 120 post-
infection
Strain Tissue Average copies/ng tissue DNA
Day 30 p.i. Day 120 p.i.
C.B-17 SCID Heart 1 4,821±915
Spleen ND 13,890±4667
Ear ND 2,154±123
Joint 6±1 3,412±1788
AKR/OlaHsd Heart ND ND
Spleen ND ND
Ear 411±128 ND
Joint 361±57 ND
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Quantiﬁcation of B. burgdorferi gene transcripts in tissue
specimens of tick-infected mice
For quantiﬁcation of gene transcripts, RNA was iso-
lated from heart, spleen, ear, and joint tissues of two
mice from each of the three murine strains at days 30
and 120 p.i.. To control for eﬀectiveness of RNA
extraction and cDNA synthesis, HPRT mRNA was
used to standardize for transcripts of the ﬁve selected B.
burgdorferi genes, ospA, zs7.a36, zs7.a66, zs7.a68 and
ospC. To account for variation in cell densities of dif-
ferent organs, transcripts were normalized to 100 hprt
copies.
When SCID mice were analysed on day 30 p.i.,
zs7.a36 transcripts were found at comparable levels in
heart and joint tissues, and most interestingly, also in ear
tissue, in which spirochetal DNA was undetectable
(Fig. 4 versus Table 4). Furthermore, ospC was ex-
pressed, though at lower levels in heart and ear tissue,
but was below detection level in joint and spleen tissue.
By day 120 p.i., zs7.a36 and ospC transcripts were
considerably reduced (up to >50-fold) in heart and ear
and were undetectable in joint and spleen tissues of
SCID mice (Fig. 4), in spite of the highly increased
spirochete burden in heart, joint, ear and spleen (1,000
fold compared to day 30 p.i.; Table 4 and Fig. 3). None
of the other transcripts, including ospA, zs7.a66 or
zs7.a68, were detectable in any of the tissues of SCID
mice at the two time points.
When testing AKR mice, in which spirochetal DNA
was detectable on day 30 p.i. in ear and joint, but not in
heart or spleen tissue (Table 4), z s7.a36 transcripts were
found only in ear and heart, but in none of the other
tissues, including joint (Fig. 4). Neither ospA, zs7.a66,
zs7.a68 nor ospC transcripts were detectable at this time
point in any of the tested organs. On day 120 p.i., when
numbers of spirochetes were below the detection limit in
all tissues of infected AKR mice, no transcripts of any of
the ﬁve genes tested were detectable, with the exception
of low amounts of zs7.a36 in the heart tissue of one
mouse. Finally, in infected BALB/c mice, where spiro-
chetal DNA could not be detected at any time point,
only low numbers of zs7.a36 transcripts were detectable
in the heart at day 30 p.i. and no transcripts were found
in any tissue at day 120 p.i..
Discussion
We show here that real-time RT-PCR is useful to
quantify B. burgdorferi burden and gene expression in
naturally infected mice. The main ﬁndings are that (1)
spirochetes seem to express ospC and zs7.a36 during the
early phase of infection, but decrease and/or cease
Fig. 3 Number of spirochetes in
tissue of mice previously
infected with B. burgdorferi via
ticks. Real-time PCR
quantiﬁcation of zs7.a68 in
naturally infected C.B-17 SCID,
AKR/OlaHsd, and BALB/c
mice (two mice/group/ time
point) were sacriﬁced on days 30
and 120 p.i. DNA was extracted
from the indicated tissues and
subjected to real time PCR,
using zs7.a68 as target gene
issues. ZS7 B.b. were quantiﬁed
per ng tissue DNA for heart,
spleen, ear, and joint in each
mouse strain at days 30 and 120
p.i.. Nd B. burgdorferi DNA
not detectable, mice where
B.burgdorferi was not detected
are indicated in parentheses,
i.e. (2)
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expression by later stages, even when expanding in an
immunodeﬁcient environment, (2) individual genes, such
as ospC and zs7.a36 may be diﬀerentially expressed in
distinct organs of the same mouse, (3) spirochetes do not
appear to express ospA, independent of the immune
status of mice and/or the severity of infection including
chronic inﬂammatory processes and (4) speciﬁc immu-
nity is a major factor in reducing spirochetal burden.
The present study which quantiﬁes spirochete burden
and gene expression in mice infected by the natural route
cannot be simply compared with previous reports in
which PCR and real time PCR analysis was applied to
mice challenged by needle infection for a similar purpose
[42, 45,62]. The reason for this is the fact that the two
routes of spirochete inoculation, i.e. tick versus needle
infection, lead to greatly diﬀering courses of infection,
induction of immune responses and onset of disease
manifestations [23, 25,55]. However, it is clear that only
the natural mode of infection will uncover strategies of
either spirochetes or mammals which are of biological
signiﬁcance and thus of relevance for the appropriate
treatment of Lyme disease.
Our present experimental protocol, using the most
reliable and sensitive primer pairs with speciﬁcity for
zs7.a68, supports the previous ﬁndings that as few as 1–
10 B. burgdorferi organisms can be detected by real-time
PCR [27, 47, 48, 63,64], though reproducibility is reduced
with low numbers of spirochetes [62]. However, as pre-
viously shown, artiﬁcial spiking of unprocessed mouse
tissue with spirochetes led to a dose-dependent inhibitory
eﬀect by tissue material on the ampliﬁcation of B. burg-
dorferi genes [27, 47, 58,63]. Furthermore, when spiro-
chetes were spiked into spleen tissue, B. burgdorferiDNA
was undetectable at concentrations used in our protocol
for determining real-time PCR sensitivity. This decreased
sensitivity of gene ampliﬁcation in the context of mouse
tissue needs some comment. Following a protocol by
which spirochetes were spiked into mouse heart tissue
aliquots (pre-digested), Wang et al. found a high corre-
lation between the expected numbers of spirochetes and
those determined by quantitative PCR in the spiked
sample after DNA processing, though with a high degree
of variability at low spirochete copy numbers [62]. Al-
though we were able to conﬁrm their results using their
protocol with both the plasmid-encoded zs7.a68 and
chromosome-encoded ﬂagellin target genes, it is unclear
to what extent either of the two methods represent the
in vivo situation. This is also true for another report
showing that the speciﬁcity and sensitivity of detection of
spirochetal DNA were not altered when isolated mouse
spleen cells rather than tissue specimens were spiked with
spirochetes [45]. In short, our results reveal diﬀerences in
the ease at which spirochetes are detected in distinct tis-
sues and the importance of developing optimal condi-
tions for detection from each particular tissue. Together
these studies also emphasize that the number of spiro-
Fig. 4 Quantiﬁcation of B.
burgdorferi gene transcripts in
tissue specimens of tick infected
C.B-17 SCID, AKR/OlaHsd
and BALB/c mice. Transcripts
speciﬁc for ospA, zs7.a36,
zs7.a66, zs7.a68, and ospC were
quantiﬁed by real time RT-PCR
in heart, spleen, ear and joint of
mice on days 30 and 120 p.i..
Data from two mice/group/time
point/tissue are shown with
error bars from multiple
testing of at least two cDNA
aliquots. Copy numbers
indicated refer to the number of
transcripts per 100 HPRT
copies per PCR reaction. No
column <0.1copies or no
transcripts detectable
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chetes determined in infected tissue by any method is
only a minimal estimate.
At day 30 p.i., spirochetes were detected in heart and
joint, but not ear and spleen tissues of SCID mice. In
disease-susceptible AKR mice, spirochetes were found in
high numbers on day 30 p.i. in ear and joint but not in
other tissues and were undetectable in all tissues of
disease-resistant BALB/c mice. The ﬁnding that spiro-
chetes were associated with ear and joint but not heart
tissue of AKR mice is consistent with other reports
[62,64], and suggests a diﬀerential tropism and expan-
sion of B. burgdorferi in mice. The observation that B.
burgdorferi was found in heart and joint, but not ear
tissue of SCID mice at day 30 may also support a pre-
vious ﬁnding on tropism in this particular strain [52].
That no spirochetes were detected in the spleen at this
time may be due to low sensitivity for this tissue, though
one cannot rule out the possibility of diﬀerential colo-
nization. The increase of spirochete numbers in all tis-
sues tested in SCID mice at late stages of infection—a
process accompanied by a time-dependent increase in
severity of arthritis and tissue destruction ([51] and
Table 3)—emphasizes the uncontrolled course of B.
burgdorferi infection in this immunocompromised
mouse strain; it also supports the assumed positive
correlation between numbers of tissue-associated spiro-
chetes and severity of pathology [9, 62, 63,64]. The
ﬁnding that B. burgdorferi was undetectable on day 120
p.i. in both AKR and BALB/c mice further supports the
notion that the spirochete burden is drastically reduced,
but not necessarily eradicated, by speciﬁc immunity, in
particular antibodies [5, 8,54]. It is presently unclear
whether the diﬀerential course of early infection in these
two immunocompetent mouse strains is due to qualita-
tive diﬀerences in their innate and/or adaptive immune
responses. However, the selective infection of joint tissue
of AKR, but not BALB/c, mice could explain the
development of clinical arthritis, including pathological
alteration in synovial tissue, in the former but not the
latter mouse strain [45,53].
The diﬀerential expression of ospC and zs7.36 in SCID
versus AKRmice on day 30 p.i. may indicate that factors
of the innate and adaptive immune system contribute to
this process of phenotypic variation, corroborating re-
lated studies, inwhichB. burgdorferiPCRandmicroarray
analyses were employed [27, 36, 37, 38,61]. The involve-
ment of speciﬁc antibodies in down-regulation of theOsps
in spirochetes is also indicated by the fact that much
higher numbers of ospC transcripts (between 10–100-fold)
were observed in spirochetes seeding most organs, except
the ear, of SCIDmice as compared to those seeding AKR
tissues on day 30 p.i.. That only zs7.a36 transcripts were
detectable in the heart tissue of BALB/C mice on day 30
p.i. argues for a very low spirochetal load in this mouse
strain (see Table 4). However, as BALB/c mice produced
B. burgdorferi-speciﬁc antibodies (Table 3), including
those toOspC ([66], and data not shown), ospCmust have
been expressed earlier in infection, at concentrations
suﬃcient to be immunogenic.
Spirochetes isolated from heart, joint and/or ear tis-
sues of SCID and AKR mice 30 days p.i. diﬀered
markedly in their levels of expression of ospC and/or
zs7.a36, respectively. A similar variation in the numbers
of gene transcripts among tissues of individual mice was
recently found in C3H mice [28]. These results not only
reveal the versatility of B. burgdorferi in situ, but also the
dilemma of designing eﬃcacious immunotherapeutic
regimens. The latter is most convincingly illustrated by
the previous report showing that immune serum to the
B. burgdorferi protein, Arp, is able, upon transfer, to
selectively resolve arthritis with no eﬀects on carditis and
infection [18].
Transcripts of zs7.a66, ospA and zs7.a68 were unde-
tectable in any of the mouse tissues tested, independent
of the genetic background and immune status of the
recipients during the observation period of 120 days p.i..
The ﬁnding that no ospA transcripts were produced by
spirochetes during the acute phase and even in a highly
inﬂammatory environment of the chronic phase of the
infection is at variance with a recent report in which
host-adapted spirochetes in mice were found to express
ospA when challenged with an inﬂammation-inducing
agent, i.e. zymosan in a dialysis chamber [13]. However,
in light of the present study it is questionable whether
this artiﬁcial system represents the genuine in vivo sit-
uation. Thus, when considering levels of B. burgdorferi
gene expression, zs7.a36 seems to be regulated diﬀer-
ently than three other lp54-encoded genes: zs7.66, zs7.68
and ospA during infection in mice. This complements the
previous notion that from 16 identiﬁed lp54-encoded
genes all but one, i.e. bba64, were down-regulated by
mammalian host-speciﬁc signals, as revealed by an
in vivo study using a membrane cultivation chamber [6].
The novel ﬁnding that expression of zs7.a36 and ospC
is down-regulated in SCID mice at later stages of
infection (day 120 p.i.), in spite of extensive expansion of
the spirochete population, indicates that host factors
other than those associated with speciﬁc immunity
interfere with gene expression in spirochetes. Although
elusive so far, it is possible that host molecules such as
ﬁbronectin [26], proteoglycan [29,35], glycosphingolipids
[4], decorin [17], complement regulators [31], plasmino-
gen [12,21] and integrins [11], which serve as receptors
for spirochetal outer surface proteins, participate in this
process(es).
To our knowledge, this is the ﬁrst report on quanti-
tative analysis of gene expression in target tissues of tick-
infected mice with distinct genotypes and diﬀerent im-
mune status at early and late stages of infection. It is
clear to us that the present study is by no means com-
prehensive. Further studies using more animals and
additional spirochete isolates, are required to verify the
present results for B.burgdorferis.s. and other species of
the highly heterogeneous [44] B.burgdorferi.s.l. complex.
However, our data do suggest that besides speciﬁc im-
mune processes, factor(s) of the innate immune response
force spirochetes to diﬀerentially change their phenotype
in the mammalian host, even in individual organs of one
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recipient. The study also demonstrates that real-time
RT-PCR analysis is a powerful tool to elucidate spiro-
chetal traits relevant for persistence and the develop-
ment of therapeutic regimens against Lyme disease.
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